Loading page
Loading page
Loading substance route
Heavy doses may be fatal. Absorption requires 15-25 minutes of sublingual contact. Expect strong metallic taste and numbness of the mouth lasting up to an hour.
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
25I-NBOH is not habit-forming and the desire to use it can actually decrease with use. It is most often self-regulating.
The LD50 has not been determined. 25I-NBOH may be fatal at heavy doses, though no deaths have been directly attributed to this compound. Its extreme potency and unpredictable dose-response curve make it particularly dangerous when insufflated, a route associated with deaths and hospitalizations with the closely related 25I-NBOMe.
Anxiety and paranoia appear to occur more readily with 25I-NBOH than with typical psychedelics, possibly due to its stimulating properties. At high doses, overwhelming cognitive alterations including confusion and sensory overload may occur.
Seizures are listed among possible physical effects. Risk may be elevated in susceptible individuals.
25I-NBOH was first synthesized in 2006 by a research team at Purdue University working under the direction of David Nichols. The compound was developed as part of ongoing investigations into serotonin receptor pharmacology, with particular interest in its potential application as a radioligand for…
Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) since November 26, 2016. Manufacturing and importing with intent to distribute, administering to others, and commercial trade are criminal offenses. Personal possession is prohibited but does not carry criminal penalties.
Specifically named as a controlled substance under Verzeichnis E of Swiss narcotics legislation. Production, possession, and distribution are regulated.
Listed under the Narcotic Drugs Punishments Act in Schedule I, which covers substances without recognized medical use. Added on August 18, 2015 through Medical Products Agency regulation HSLF-FS 2015:12, where it appears under both the name '25I-NBOH' and its chemical designation.
Controlled as a Class A substance under the Misuse of Drugs Act 1971 through the N-benzylphenethylamine catch-all clause, which encompasses structurally related compounds in this chemical class. Class A substances carry the most severe penalties under UK drug law.
14 sources cited
